Back to rankings

MetLife Inc (MET)

Overvalued
Financial ServicesInsurance - LifeUnited States

Fundamental

46

Price

$94.16

Market Cap

$60.89B

Part 1 · What the company is worth

Overview

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it offers fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity and funded reinsurance solutions; credit insurance products; accident & health products covering hospitalization, cancer, critical illness, income protection, and scheduled medical reimbursement plans; and protection against long-term health care services. The company was incorporated in 1999 and is based in New York, New York.

No editorial profile for this company yet

Direct competitors

Who this company fights with for the same customers

Compare

Generated on September 19, 2026 with claude-haiku-4-5 — shared with all users

P/E: 10.3Score: 63Market cap: $40.05B

Prudential bids against MetLife for the same large-employer group life and disability contracts and for the same pension risk transfer and institutional retirement mandates in the United States, often splitting the biggest deals between the two.

P/E: 20.4Score: 58Market cap: $14.42B

Unum sells the same workplace benefits package — group disability, group life and voluntary coverages — to the same US employers and brokers that MetLife's Group Benefits segment serves.

P/E: 7.9Score: 89Market cap: $34.14B

The Hartford's Employee Benefits arm competes head-on with MetLife for group life, disability and absence-management programmes at US employers of every size.

P/E: 12.1Score: 61Market cap: $56.93B

Aflac competes with MetLife in the same two markets that matter most to it: voluntary supplemental benefits sold at the US workplace, and life and health policies sold to Japanese households.

P/E: 16.1Score: 62Market cap: $24.66B

Principal chases the same small and mid-sized employers for group benefits and workplace retirement plans, and competes with MetLife Investment Management for institutional asset mandates.

Lincoln National CorporationLNC

Lincoln's Group Protection unit and its individual life and annuity lines target the same US employers and retail savers that MetLife pursues.

Balance Sheet & Liquidity

Revenue

$2.68B

Trailing 12 months (through 6/30/2026)

Net Income

$3.63B

Trailing 12 months (through 6/30/2026)

Free Cash Flow

-

Total Equity

$28.40B

Total Liabilities

$716.25B

Current Ratio

0.19

Interest Coverage

8.48

Debt/EBITDA

2.43

Earnings Per Share

Revenue & Net Income

Free Cash Flow

Income Breakdown

Historical statement

Margins over time

Debt over time

How heavy the debt is

Growth grid

Growth — Revenue

Fair Value Estimation

InsuranceOvervalued

Fair Value

$78.06

Current Price

$94.16

Margin of Safety

-20.6%

Fair Value Range

$56.93 - $99.20

Spread across the valuation methods used, not a statistically calibrated confidence interval.

Estimation Methods

Analyst price target:$105.75
Discounted cash flow (DCF):Not applicable to this type of company
Earnings multiple (P/E):$46.32
Graham growth formula:Not applicable to this type of company
Earnings power value (EPV):Not applicable to this type of company
Justified P/B:$79.02
Dividend discount (Gordon):$53.74
P/FFO, funds from operations:Not applicable to this type of company
Mid-cycle earnings:Not applicable to this type of company
Revenue multiple:Not applicable to this type of company
Analyst Consensus:Buy (17B / 7H / 0S)
Last Earnings Surprise:+4.93%

Valuation Metrics

P/E Ratio

18.00

ROE

11.9%

P/B Ratio

2.18

P/FCF

-

Gross Margin

-

ROIC

-

Profitability Radar

Value Creation (Economic Moat)

ROIC

-

WACC

7.9%

ROIC − WACC

-

Fundamental Analysis Criteria

Passed (11)

  • Price CAGR 7.30%
  • P/B Ratio 2.18
  • Operating Margin 245.0%
  • Interest Coverage
  • Debt/EBITDA
  • Low reliance on intangibles
  • ROE 12.9%
  • Analyst Consensus 71% Buy
  • Earnings Surprise avg 5.2%
  • Earnings Quality (OCF/NI) 4.29
  • Share Dilution -3.7%

Failed (9)

  • EPS shows upward trend
  • EPS CAGR -0.84%
  • Debt/Equity ratio
  • Return on Tangible Assets
  • Price below Graham Number
  • DCF valuation (Unknown)
  • Revenue Growth 5Y 2.6%
  • Net Margin Trend 135.3% vs 184.4%
  • Piotroski F-Score 4/9

Unavailable (8)

  • ROIC NaN%
  • Gross Margin NaN%
  • P/FCF NaN
  • Dividend Payout NaN%
  • Positive Free Cash Flow
  • CapEx intensity
  • Current Ratio
  • PEG Ratio (need PE > 0 and growth > 0)

Piotroski F-Score

4/9

Mixed signals: some areas need attention

score
criteria

Earnings Quality

4.29

High quality: earnings backed by cash

Share Dilution

-3.7%

Buying back shares. Shareholder friendly

Institutional Holdings

Governance

Executive Team

NameTitleAge
Mr. Michel Abbas KhalafCEO, President & Director-
Mr. Bill PappasExecutive VP and Head of Global Technology & Operations55
Ms. Marlene Beverly DebelExecutive VP, Chief Risk Officer & Head of Insurance Investments58
Mr. Ramy TadrosRegional President of U.S. Business & Head of MetLife Holdings49
Mr. John Arthur HallSenior VP, Head of Investor Relations & Executive VP and Treasurer-
Ms. Monica M. CurtisExecutive VP, Chief Legal Officer & Head of Government Relations42
Ms. Jane SlusarkChief Communications Officer-
Mr. Michael RobertsExecutive VP & Chief Marketing Officer-
Ms. Shurawl SibbliesExecutive VP & Chief Human Resources Officer53
Mr. Randy StramSenior Vice President of Group Benefits-

Audit Risk

4

Board Risk

3

Compensation Risk

1

Shareholder Rights Risk

9

Part 2 · The price and when to enter

This part won't tell you whether the company is worth owning: it helps you choose when to buy it, once the fundamentals have convinced you. Inside: technical analysis, potential, historical drawdowns, gamma exposure.

Documents

  • Annual Report (10-K)

    A yearly overview of the business, its financial results, and the risks it faces.

    Filed on 2026-02-19

    View document
  • Quarterly Report (10-Q)

    A snapshot of financial performance for the most recent three-month period.

    Filed on 2026-08-06

    View document
  • Current Report (8-K)

    An announcement of a major event, such as a leadership change or big news.

    Filed on 2026-09-24

    View document

via SEC EDGAR

Income History

via SEC EDGAR

Latest News

Recent headlines for MET, sourced from Markets Gazette.

  • 8/5/2026POSITIVE
    MetLife’s Earnings Beat Wall Street Expectations

    MetLife Inc. reported second-quarter earnings that exceeded Wall Street's projections, driven by robust underwriting performance and significant volume growth. The company's success is attributed in part to its strategic five-year plan, initiated in late 2024, which appears to be yielding positive results. This earnings beat suggests effective operational management and strategic execution, potentially signaling a favorable outlook for the insurance giant. Investors will be watching for continued momentum and the long-term impact of the company's strategic initiatives.

  • 5/28/2026NEUTRAL
    MetLife Clashes With Ares Over Struggling Football Investment

    MetLife Inc. is reportedly in a dispute with Ares Management regarding the restructuring of Eagle Football, a holding company with stakes in several football clubs, notably Olympique Lyonnais. The disagreement centers on the financial strategy and future direction of the football investment group. While the specific details of the clash are not fully disclosed, such disputes can introduce uncertainty for investors in the involved entities. The outcome could impact the valuation and operational stability of the football assets.

  • 5/6/2026POSITIVE
    MetLife’s Improved PE Returns Lift Earnings Above Expectations

    MetLife Inc. reported first-quarter earnings that exceeded Wall Street consensus, primarily driven by enhanced returns from its private equity investments. The insurer's ability to leverage its private equity portfolio for higher gains signals effective asset management and a robust strategy in alternative investments. This performance suggests a positive outlook for MetLife's financial health and could be interpreted by investors as a sign of strong operational execution and potential for future growth, especially in its alternative asset classes.

  • 2/24/2026NEUTRAL
    Polymarket users favor Meteora in bets over ZachXBT crypto takedown

    Polymarket users have wagered over $7 million on the outcome of the investigation by prominent crypto sleuth ZachXBT, with an announcement expected on Thursday. The betting patterns indicate a preference for Meteora, suggesting many investors believe the DeFi protocol will navigate the inquiry without severe repercussions. This speculative activity underscores the high tension and uncertainty surrounding crypto projects under scrutiny, as the market attempts to anticipate the impact of potential 'takedowns'. The impending announcement will be crucial in determining the future direction of the MET token, introducing potential volatility.

via Markets Gazette